Mutant K-ras2 in serum
- PMID: 12740358
- PMCID: PMC1773684
- DOI: 10.1136/gut.52.6.915-a
Mutant K-ras2 in serum
Comment on
-
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.Gut. 2003 Jan;52(1):101-8. doi: 10.1136/gut.52.1.101. Gut. 2003. PMID: 12477769 Free PMC article.
References
-
- Andreyev HJN, Norman AR, Cunningham D, et al. Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study. J Natl Cancer Inst 1998;90:675–84. - PubMed
-
- Al-Mulla F, Milner-White E, Going J, et al. Structural differences between valine12 and aspartate 12 Ras proteins may modify carcinoma aggression. J Pathol 1999;187:433–8. - PubMed
-
- O’Sullivan GC, Sheehan D, Clarke A, et al. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999;116:543–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous